A Study of Subjects Switched to Lurasidone for the Treatment of Schizophrenia or Schizoaffective Disorder

NCT01143090 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

149

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Lurasidone HCl

Sponsor

Sumitomo Pharma America, Inc.